American Society for Clinical Investigation honors 10 Vanderbilt physicians
Four Vanderbilt University Medical Center faculty members have been elected this year to membership in the American Society for Clinical
Diabetes drug may improve asthma
New biomarker finding strengthens the case for using GLP-1R agonists to treat patients with Type 2 diabetes who also suffer from asthma.
Research Staff Awards honor contributions to discovery
Laboratory and administrative personnel at Vanderbilt University Medical Center were honored on March 31 for research excellence during t
Vanderbilt researchers envision the potential to grow new lungs
Using a four-dimensional microscope that allows them to watch a tissue putting itself together, researchers at Vanderbilt University Medical Center have achieved a rare feat in science — they have shattered a long-standing dogma about how the lung develops.
Panel considers ways to improve vaccine readiness, restore trust
One consequence of the COVID-19 pandemic is the continued erosion of trust in health care, a growing rift between doctor and patient epitomized by large numbers of people who hesitate or refuse to be vaccinated against the virus.
Gene variants and transplant drug dose
Tacrolimus — a commonly used immunosuppressive drug for lung transplant recipients — requires strict monitoring of concentrations because of variability in metabolism and adverse effects at high levels.
Four named to academic health leadership program
Four faculty members from Vanderbilt University Medical Center have been selected to participate in the highly competitive 2023-2024 Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) program, with two on the ELAM track now celebrating its 28th year, and two on the Executive Leadership in Academic Health Care (ELH) track launched in 2022.
Study finds early RSV infection linked to significantly increased risk of asthma in children
A new observational study by Vanderbilt University Medical Center researchers has found that RSV infection in the first year of life is associated with a significantly increased risk of asthma in children. The study, the first to look at the effects of RSV infections of all different severities on childhood asthma risk at a population level, was published recently in the journal The Lancet.